Palo Alto Investors LP
Top Portfolio Positions
51 positions ·
$653,863,072 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| INSM |
INSMED Inc
Healthcare
|
415,269 | $67,904,786 | 10.39% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
2,872,695 | $63,946,190 | 9.78% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
921,607 | $62,789,084 | 9.60% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
685,182 | $38,705,931 | 5.92% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
62,809 | $37,244,480 | 5.70% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
638,161 | $35,392,409 | 5.41% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
325,175 | $30,039,666 | 4.59% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
1,652,972 | $29,968,382 | 4.58% | |
| BIIB |
Biogen Inc.
Healthcare
|
140,719 | $25,798,014 | 3.95% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
401,719 | $25,685,912 | 3.93% |
Portfolio Trend
25 quarters · across all stocks
Holdings in BMRN
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,705,931 | 685,182 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,349,994 | 746,256 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $40,837,019 | 754,007 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $46,200,635 | 840,470 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $70,068,422 | 991,207 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $70,151,394 | 1,067,266 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $76,620,036 | 1,090,056 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $93,046,649 | 1,130,167 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $99,093,256 | 1,134,569 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $144,702,218 | 1,500,749 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $162,009,976 | 1,831,035 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $158,714,113 | 1,831,035 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $178,049,843 | 1,831,035 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $195,162,580 | 1,885,811 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $167,527,984 | 1,976,265 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $170,825,980 | 2,061,373 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $164,964,239 | 2,139,614 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $195,514,132 | 2,212,950 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $171,038,905 | 2,212,950 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $184,648,548 | 2,212,950 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $166,556,182 | 2,205,750 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $188,976,334 | 2,155,050 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $131,812,404 | 1,732,550 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $173,409,873 | 1,405,950 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $130,481,773 | 1,544,163 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||